Micaela Campagna
Family Medicine · Gainesville, GANPI 1326706516
Payments from drug & device makers
Across 132 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$453
- Boehringer Ingelheim$207
- GSK$193
- Amgen$181
- Pfizer$172
- Lilly USA, LLC$171
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,40292%
- Education$2008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $453 |
| Boehringer Ingelheim | 11 | $207 |
| GSK | 10 | $193 |
| Amgen | 13 | $181 |
| Pfizer | 8 | $172 |
| Lilly USA, LLC | 10 | $171 |
| Merck | 7 | $149 |
| Seagen Inc. | 1 | $100 |
| Novo Nordisk | 6 | $95 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $90 |
| Exact Sciences | 4 | $73 |
| Shield Therapeutics Inc | 4 | $72 |
| Idorsia Pharmaceuticals US Inc | 3 | $70 |
| Caris MPI, Inc. | 1 | $65 |
| AbbVie | 2 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Myriad Genetic Laboratories, Inc. | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Sanofi Pasteur Inc. | 1 | $28 |
| Vertex | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Novartis | 1 | $17 |
| Aspira Women's Health Inc | 1 | $15 |
How this compares
$2,602 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 21 | $34,069 |
| FarxigaDapagliflozin Propanediol | 20 | $28,702 |
| OzempicSemaglutide | 15 | $19,418 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,156 |
| Atorvastatin Calcium | 90 | $978 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $659 |
| Diclofenac Sodium | 11 | $408 |
| Gabapentin | 36 | $371 |
| Lisinopril | 56 | $308 |
| Omeprazole | 24 | $296 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $288 |
| Levothyroxine Sodium | 21 | $259 |
| Montelukast Sodium | 22 | $226 |
| Amlodipine Besylate | 59 | $217 |
| Metformin Hcl | 36 | $191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $207 | $34,06921 claims |
| AstraZenecaFarxiga | $453 | $28,70220 claims |
| Novo NordiskOzempic | $95 | $19,41815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Gainesville
- Angela RitterGainesville$15.8M
- Joseph SurberColumbus$16.6M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.